ZA918636B - Process for the preparation of piperazine derivatives - Google Patents

Process for the preparation of piperazine derivatives

Info

Publication number
ZA918636B
ZA918636B ZA918636A ZA918636A ZA918636B ZA 918636 B ZA918636 B ZA 918636B ZA 918636 A ZA918636 A ZA 918636A ZA 918636 A ZA918636 A ZA 918636A ZA 918636 B ZA918636 B ZA 918636B
Authority
ZA
South Africa
Prior art keywords
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
ZA918636A
Other languages
English (en)
Inventor
Eva Agai-Nee-Csongor
Agai Nee Csongor Eva
Kalman Harsanyi
Harsanyi Kalman
Aniko Demeter-Nee-Szabo
Demeter Nee Szabo Aniko
Eva Vajda
Vajda Eva
Tibor Gizur
Gizur Tibor
Ferenc Trischler
Trischler Ferenc
Attila Csehi
Csehi Attila
Gyoergyi Szabo-Nee-Komlosi
Szabo Nee Komlosi Gyoergyi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ZA918636B publication Critical patent/ZA918636B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA918636A 1990-10-31 1991-10-30 Process for the preparation of piperazine derivatives ZA918636B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU906953A HU209723B (en) 1990-10-31 1990-10-31 Process for producing of piperazine derivatives

Publications (1)

Publication Number Publication Date
ZA918636B true ZA918636B (en) 1992-08-26

Family

ID=10972063

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918636A ZA918636B (en) 1990-10-31 1991-10-30 Process for the preparation of piperazine derivatives

Country Status (11)

Country Link
EP (1) EP0483932A1 (xx)
JP (1) JPH04264078A (xx)
KR (1) KR920008018A (xx)
AU (1) AU8683091A (xx)
CA (1) CA2054544A1 (xx)
CS (1) CS329491A3 (xx)
HU (1) HU209723B (xx)
NO (1) NO914250L (xx)
PL (1) PL292227A1 (xx)
PT (1) PT99368A (xx)
ZA (1) ZA918636B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0585500A1 (en) * 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl piperazineacetamides as antimuscarinic agents
US6677336B2 (en) 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
US6451798B2 (en) 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
US6552023B2 (en) 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
WO2001062711A2 (en) 2000-02-22 2001-08-30 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
AU2001238590A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted piperazine compounds
AU3862301A (en) * 2000-02-22 2001-09-03 Cv Therapeutics Inc Substituted piperazine compounds
KR100797835B1 (ko) * 2001-08-13 2008-01-24 주식회사 포스코 핀치롤의 이물질 제거장치
WO2004063180A1 (en) 2003-01-03 2004-07-29 Cv Therapeutics, Inc. Substituted heterocyclic compounds
JP2007518677A (ja) 2003-06-23 2007-07-12 シーブイ・セラピューティクス・インコーポレイテッド 脂肪酸酸化インヒビターとしてのピペラジンおよびピペリジンのウレア誘導体
CA2550257A1 (en) * 2003-12-18 2005-07-07 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
WO2006008753A1 (en) * 2004-07-19 2006-01-26 Unichem Laboratories Limited Crystalline and amorphous form of ranolazine and the process for manufacturing them
WO2008047388A2 (en) * 2006-10-20 2008-04-24 Ind-Swift Laboratories Limited Improved process for the preparation of ranolazine
WO2008139492A2 (en) * 2007-05-15 2008-11-20 Natco Pharma Limited A process for the preparation of highly pure ranolazine base
US20110300218A1 (en) * 2008-09-09 2011-12-08 Actavis Group Ptc Ehf Novel solid state forms of ranolazine salts
US20110223213A1 (en) * 2008-10-15 2011-09-15 Actavis Group Ptc Ehf Highly pure ranolazine or a pharmaceutically acceptable salt thereof
WO2010097805A1 (en) 2009-02-24 2010-09-02 Lupin Limited A process for the preparation of ranolazine
EP3782992A1 (en) 2015-03-10 2021-02-24 Unichem Laboratories Limited Novel process for the preparation of ranolazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB662283A (en) * 1948-08-02 1951-12-05 Rhone Poulenc Sa Improvements in or relating to piperazine compounds
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry

Also Published As

Publication number Publication date
AU8683091A (en) 1992-05-07
KR920008018A (ko) 1992-05-27
NO914250D0 (no) 1991-10-30
NO914250L (no) 1992-05-04
PT99368A (pt) 1992-09-30
HUT62278A (en) 1993-04-28
PL292227A1 (en) 1992-06-26
JPH04264078A (ja) 1992-09-18
HU209723B (en) 1994-10-28
EP0483932A1 (en) 1992-05-06
CS329491A3 (en) 1992-05-13
HU906953D0 (en) 1991-05-28
CA2054544A1 (en) 1992-05-01

Similar Documents

Publication Publication Date Title
HU913664D0 (en) Process for the production of indian- and kinoline derivatives
ZA918636B (en) Process for the preparation of piperazine derivatives
GR3021081T3 (en) Process for the preparation of nitroguanidine derivatives
HU9200933D0 (en) Process for the production of kinoline derivatives
HU913280D0 (en) Process for the production of 8-chloro-kinoline derivatives
AU8251891A (en) Process for the preparation of 1-alkylisoquinoline derivatives
EP0476649A3 (en) Process for the preparation of carbapeneme compounds
ZA915396B (en) Process for the preparation of 1-hydroxymethylpyrazoles
EP0439745A3 (en) Process for the preparation of 2-chloro-5-methyl-pyridine
HU910937D0 (en) Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives
IL97512A0 (en) Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles
EP0444460A3 (en) Process for the preparation of acrolin
EP0449778A3 (en) Process for the preparation of hydroxyphenylepropionates
IL98877A0 (en) Process for the preparation of n-alkylsulfonylamino-sulfonylureas
EP0450180A3 (en) Process for the preparation of aminoethanol derivatives
IL103922A0 (en) Process for the preparation of trifluorobenzene derivatives
GB9205920D0 (en) Process for the preparation of pyrethroide derivatives
GB2201417B (en) Piperazine derivatives and process for the preparation thereof
IL98876A0 (en) Process for the preparation of n-alkylsulfonyl aminosulfonylureas
EP0459242A3 (en) Process for the preparation of phenolethers
NZ233012A (en) Process for the preparation of thieno-triazolo-diazepine derivatives
HU903050D0 (en) Process for the preparation of 3-amino-propyl-chloride derivatives
EP0446925A3 (en) Process for the preparation of beta-resorcylic acid derivatives
EP0467308A3 (en) Process for the preparation of 2-hydroxy-3-halogen-5-nitropyridines
ZA915762B (en) Process for the preparation of 6-(3-substitutedamino-propionyl)-7-deacetylforskolin derivatives